Compared to low-grade gliomas, these tumor-derived endothelial cells have different angiogenic mediators, such as hypoxic inducible factor 1 alpha (HIF-1α), neural cell adhesion molecule, FGF, and angiopoietin receptor Tie-2 [11]. The gene discussed is HIF1A; the disease is central nervous system cancer.